Defense Supply Center Philadelphia, Attn: DSCP-M Bldg 9-4, 2800 S. 20th Street, Philadelphia, PA 19145-5099

65 -- SERUM BLOOD GLUCOSE MONITORS, TEST STRIPS, AND SOFTWARE PRODUCT GROUP DUE 113098 POC Stephen Lewis, Contract Specialist (215)737-5649 or Mike McKeown, Contracting Officer (215) 737-5746 E-MAIL: slewis, Contract Specialist and mmckeown, Contracting, slewis@dscp.dla.mil or mmckeown@dscp.dla.mil. The Defense Supply Center Philadelphia(DSCP) intends to issue a solicitation for a single test strip for serum blood glucose monitoring for the Department of Defense (DOD) Basic Core Formulary. Additionally, the DOD will require the sucessful vendor to supply monitors and software for downloading patient specific information that the monitor is capable of recording. Monitors will be supplied to diabetic educators and other health care providers at military medical treatment facilities who require the ability to track compliance and asses patient outcomes. The product must be FDA approved as of the issuance date of solicitation. The product must also function using biosensor technology. Prior to issuance of the solicitation, companies are hereby invited, but not required, to make presentations about the functional and technical attributes of their serum blood glucose monitors and test strips at the DOD Pharmacoeconomic Center, Fort Sam Houston, Texas, between 26-30 October 1998. Information received during these presentations will assist in identifying the specification and evaluation factors that will be used to determine the manufacturers that will meet the yet to be defined requirements of the solicitation. One presentation will be scheduled for each company. Each presentation will be limited to no more than one hour. Companies may schedule their presentations by contacting MAJ Donald DeGroff at the DOD Pharmoeconomic Center, (210) 295-9635 or 295-1271. Companies are encouraged to provide the following information regarding their product: (1) the memory capability and capacity of the respective biosensor type monitors (2) the type of packaging available for test strips (3) information pertaining the time required to obtain a serum blood glucose test (4) the volume of blood required to complete a sucessful test and obtain an accurate reading of serum blood glucose (5) any other infromation pertaining to significant differences between serum blood glucose test strips and associated monitors. NOTE: The Government may use information provided during the presentations when drafting its solicitation. However, all awards will be based on the offers received in response to the actual solicitation and the evaluation ctiteria set forth therin. Posted 10/05/98 (W-SN258385). (0278)

Loren Data Corp. http://www.ld.com (SYN# 0228 19981007\65-0001.SOL)